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Among more than 200 human papillomavirus (HPV) types presumed to exist, 18 ‘‘high-risk’’ HPV types are frequently found in
anogenital cancer. The best studied types are HPV-16 and 18, which are only distantly related to one another and form two separate
phylogenetic branches, each including six closely related types. HPV-30, 53, 56, and 66 form a third phylogenetic branch unrelated to HPV-
16 and 18. Worldwide comparison of HPV-16 and 18 isolates revealed a distribution of variant genomes that correlated with the geographic
origin and the ethnicity of the infected cohort and led to the concept of unique African, European, Asian, and Native American HPV-16 and
18 variants. Here, we address the question whether similar phylogenies are found for HPV-53, 56, and 66 by determining the sequence of the
long control regions (LCR) of these HPVs in samples from Europe, Asia, and Africa, and from immigrant societies in North and South
America. Phylogenetic trees calculated from point mutations and a few insertions/deletions affecting 2–4.2% of the nucleotide sequences
were distinct for each of the three HPVs and divergent from HPV-16 and 18. In contrast to the ‘‘star-phylogenies’’ formed by HPV-16 and 18
variants, 44 HPV-53 isolates represented nine variants, which formed two deep dichotomic branches reminiscent of the beginning split into
two new taxa, as recently observed for subtypes of HPV-44 and 68. A total of 66 HPV-56 isolates represented 17 variants, which formed
three branches preferentially containing European, Asian, and African variants. Variants of a fourth branch, deeply separated from the other
three, were characterized by a 25 bp insertion and created a dichotomy rather than star-like phylogeny. As it contained isolates from cohorts
in all continents, it may have evolved before the spread of humans into all continents. 18 of 31 HPV-66 isolates represented the prototype
clone, which was found in all parts of the world, while the remaining 13 clones formed 11 branches without any geographic association. Our
findings confirm the notion of a quantitatively limited genomic diversity of each HPV type with some correlation to the geographic origin of0042-6822/$ - s
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J.C. Prado et al. / Virology 340 (2005) 95–10496the sample. In addition, we observed in some variants of these three HPV types mutations that affect the amino acid sequence of the E6
oncoproteins and the L1 capsid protein, supporting the possibility of immunogenic and oncogenic diversity between variants of any HPV
type.
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The taxonomy of papillomaviruses (PVs) based on
phylogeny is now a mature field of research. PVs form a
separate family and are further classified into genera and
species as recognized by the International Committee on
Taxonomy of Viruses (de Villiers et al., 2004). On lower
taxonomic levels, PVs are classified as types, subtypes, and
variants, and molecular, clinical, and epidemiological
research normally addresses PVs on these latter three levels
of taxonomy. Among more than 200 different human
papillomavirus (HPV) types, close to one hundred being
formally described (Antonsson et al., 2000; Chan et al.,
1995; de Villiers, 1989; de Villiers et al., 2004), 18 HPV
types are of particular interest as they are more likely to be
associated with anogenital cancer and therefore classified as
‘‘high-risk’’ HPV types (Munoz et al., 2003). Paradigms for
the high-risk HPVs are HPV-16 and 18, which are only
remotely related to one another. Each of HPV-16 and 18
form, together with six other HPV types, two separate
phylogenetic branches, which are now called ‘‘species’’ (de
Villiers et al., 2004). A third branch (species) of high-risk
HPV types is formed by HPV-30, 53, 56, and 66.
An HPV type is defined as a separate taxon, when the
nucleotide sequence of its L1 gene differs from that of any
other HPV type by at least 10%. The additional term
‘‘subtype’’ was defined to identify HPV genomes whose L1
nucleotide sequence is 2–10% different from that of the
closest type (de Villiers et al., 2004). Presently, we know
only of four HPV subtypes, and recent analyses of two of
them have shown that these evolved dichotomically into
independent taxa, i.e., into future HPV types (Calleja-
Macias et al., in press).
In contrast to the scarce occurrence of subtypes, each
HPV type can be re-isolated in the form of genomic
variants, whose number is small in comparison to the quasi-
species formed by rapidly evolving RNA viruses. Variants
of HPV types differ by less than 2% of their L1 nucleotide
sequence, but slightly more in the long control region
(LCR), which does not encode genes and is therefore less
restricted to give rise to viable mutations (Stewart et al.,
1996; Yamada et al., 1997). Previous studies have shown
that specific genomic variants have increased prevalence in
some parts of the world and sometimes correlate with the
predominant ethnic group of that geographic region (Deau
et al., 1993; Ho et al., 1993; Ong et al., 1993; Heinzel et al.,
1995; Stewart et al., 1996; Chan et al., 1997; Yamada et al.,
1997). Most notably, variants of HPV-16 and HPV-18 formphylogenetic trees with multiple short branches (‘‘star-
phylogenies’’) with high prevalence of variants of each
branch either in Africa, or Europe, or East Asia. One branch
of each type extends from East Asia into the Americas.
Thus, these trees are reminiscent of the evolution and
worldwide spread of the human host of the virus (Bernard,
1994) and suggested that certain variants diverged approx-
imately at the same time when the major human ethnic
groups formed.
Here, we report a study of the genomic diversity of
variants of the closely related high-risk types HPV-53, 56,
and 66. The three phylogenetic trees show similarities to
but also differences from the patterns observed for HPV-16
and 18. Several geographic clusters of HPV-53 and 56
variants established similarities, while discrepancies include
the deep dichotomic branching of the HPV-53 and 56 trees,
possibly the early stage of a split into two taxa and a lack
of clear geographic association of HPV-66 variants. In
contrast to the HPV-16 and 18 trees, these phylogenies
indicate that intratype diversification may have occurred
well before and after the evolution of human ethnic groups
and not necessarily in linkage to the evolution of the human
host. The low prevalence of HPV-53, 56, and 66 may
indicate a slower evolution and slower spread of these
viruses than that observed in the more common HPV types.
Our data bases confirm that each HPV type shows only
modest diversification of its genome sequence and the
encoded proteins, confirming that HPVs evolve slowly and
could be much more accessible targets of vaccination and
pharmaceutical approaches than many rapidly evolving
RNA viruses. Our study also reports diversity between the
E6 oncoproteins and the L1 capsid proteins of variants of
each type, alerting us to the need to consider variant
diversity in epidemiological, etiological, and vaccination
research.Results
Genomic diversity of HPV-53 isolates
HPV-53 was originally isolated from a cervical swab of a
pregnant woman without cytological or clinical abnormality
(Gallahan et al., 1989). Subsequently, HPV-53 been detected
in smears graded as normal (Wheeler et al., 1993; Lazcano-
Ponce et al., 2001) as well as dysplastic lesions (Isacson et
al., 1996; Meyer et al., 2001) and is considered a
‘‘probable’’ high risk HPV type (Munoz et al., 2003). While
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cervical cancer (Munoz et al., 2003), epidemiological
studies have reported prevalence up to 6.3% (Lazcano-
Ponce et al., 2001).
Among 44 HPV-53 variants, we observed mutations in
21 positions, namely 20 single nucleotide exchanges and
one 4 bp (GGGA) insertion. In the 501 bp segment that was
phylogenetically evaluated, maximal distances between any
two variants were 21 mutations (4.2%). A phylogenetic tree
calculated from these variant sequences shows deeply
dichotomical branching (Fig. 1). Such dichotomy has been
recently observed in the trees of the HPV subtype pairs
HPV-44/55 and 68a/b (Calleja-Macias et al., 2005), but it
has not been described in a tree of HPV variants. One
branch contains the HPV-53 reference clone and 15 isolates
representing four variants. Most isolates of this branch
originated from Africa or potential African immigrant
populations. The second branch contained 28 isolates
representing five variant genomes. One variant was repre-
sented in four out of five isolates from Asia (Hong Kong)
but included an equal number of isolates from Scotland.
Therefore, we cannot identify a phylogenetic cluster likely
predominating in Asia.
Genomic diversity of HPV-56 isolates
HPV-56 DNA was originally identified by low-strin-
gency hybridization with an HPV-31 probe, in a specimen
(GU56) of cervical intraepithelial neoplasia (CIN) obtained
from a woman in the Washington D.C. metropolitan area
(Lorincz et al., 1989). HPV-56 has also been found in
cervical cancer and all grades of precursor lesions. Some
authors believe that this type is under-represented in
invasive cancer compared to preinvasive cervical lesions
(Clifford et al., 2003). It is generally considered to be a
high-risk type (Munoz et al., 2003), and while not being
among the eight most common HPV types in cervical
cancer, prevalence of this type is still generally observed
between 1.1–10.9% (Franceschi et al., 2005).
The 59 HPV-56 isolates represented 17 different genomic
variants based on point mutations in 25 positions and a 41
bp deletion. Maximal distances in the phylogenetically
evaluated 549 bp segment (counting the deletion as a single
mutation) between any two variants were 11 mutations
(2%). Although we counted the 41 bp deletion only as a
single mutational event, presence or absence of this segment
divided the phylogenetic tree into two deep dichotomically
separated branches. One branch was formed by six variants,
which contained the 41 bp sequence, and included the
reference clone, four closely related variants, and the
remotely related variant BR4114. The other branch con-
tained eleven variants: three variants of this branch had a
high prevalence in the South African and Hong Kong cohort
as well as in cohorts from Europe or presumed European
immigrants and might have a specificity for geographic
region or ethnicity (Fig. 2).Genomic diversity of HPV-66 isolates
HPV-66 was originally detected in a biopsy of a 38-year-
old patient with a stage I invasive squamous-cell carcinoma
of the uterine cervix (Tawheed et al., 1991) and is
considered a ‘‘probable’’ high-risk type (Munoz et al.,
2003). HPV-66 has been reported with a prevalence up to
14.5% in CIN II/III (De Vuyst et al., 2003) but was not
found among the eight most common types in cervical
cancer (Munoz et al., 2003).
Among the HPV-66 variants, there were seventeen
nucleotide exchanges and one 2 bp insertion, with a total
of 12 different variants and maximal distances of 16
mutations in the 621 bp (2.6%) of the phylogenetically
evaluated segment. 18 of the 31 isolates contained the HPV-
66 reference clone, and the other eleven variants did not
show any geographic clustering. The most distantly related
variant came from a patient from Morocco, a country whose
intratype HPV diversity has never been studied before
(Fig. 3).
Diversity in the E6 oncogene and a conserved part of the L1
gene
In order to evaluate the potential for functional changes
of HPV proteins, whose genes are linked to LCR variation,
we compared HPV-53, 56, and 66 variants selected from
remote branches of the phylogenetic tree and determined
the sequence of their E6 genes and the corresponding E6
oncoproteins as well as the sequence of that part of the L1
gene that is bracketed by the MY09/11 amplification
primers, encoding about a third of the major capsid protein.
These sequence data are summarized in Fig. 4.
Surprisingly, the E6 genes of HPV-53 variants showed
significant distances between any two variants and between
the variants and the reference clone, namely up to 16
nucleotides (3.6% of the nucleotide sequence), approaching
the diversity of the LCR. In the case of one variant
(ED1817), this affected eleven amino acid residues or
7.3% of the E6 oncoprotein. Diversity was much lower in
the case of HPV-56 and 66, with maximal distances among
any two variants of seven and six nucleotides (1.5 and
1.3%). In many cases, these changes did not affect the
amino acid sequence, while one, two, and three amino acids
were exchanged in others. Seven, six, and six, respectively,
nucleotides were affected in the L1 gene segment, amount-
ing to diversities of 1.6 and 1.3% and affecting normally
none of the amino acids, but leading in some variants to one
and two amino acid exchanges.Discussion
The high-risk HPV types involved in anogenital carcino-
genesis form three phylogenetic groups (now called
‘‘species’’), two of which are affiliated with HPV-16 and
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consisting of the little studied HPV types 30, 53, 56, and 66
(HPV species 6) (de Villiers et al., 2004). It was the
objective of our research to analyze this latter group, on the
one hand, to investigate whether past models of intratype
diversification of HPV types, built largely on the paradigms
of HPV-16 and 18, but possibly supported by HPV-31 and
35 (Calleja-Macias et al., 2004), would apply to all genital
and cancer associated HPVs, and on the other hand, to begin
the establishment of a data base for future epidemiological,
etiological, pharmaceutical, and vaccination studies should
the genomic diversity affect the virally encoded proteins.
The most important outcome of this study is the low level
of genomic distances (2–4.2%) that were observed for the
various geographic isolates of HPV-53, 56, and 66. This is a
remarkable observation when one considers that the LCR is
under less mutations restrictions and therefore more diverse
in sequence than coding regions of the HPV genome. This
corresponded to a much lower diversity of the E6 and L1
genes for the most distant variants of each type. This finding
may imply that normally only moderate functional differ-
ences exist between variants within each type, which is of
relevance for epidemiological, etiological, pharmaceutical,
and vaccination research. These small intragenic mutations
may, however, lead to functional change, which are
particularly likely to be expected from the highly diverse
HPV-53 E6 variants, one showing eleven amino acid
exchanges. It should be noted that transcriptional as well
as epidemiological studies have identified quite significant
functional differences between variants of HPV-16, which
seem to stem from diversity in the LCR as well as in genes
(Stewart et al., 1996; Yamada et al., 1997; Xi et al., 1997,
1998; Kammer et al., 2000, 2002; Villa et al., 2000; Sichero
et al., 2005).
Phylogenetically, it is remarkable that most HPV types
investigated so far show a similar and very limited diversity
of genomes. This also appears to apply to HPV-53, 56, and
66. Each isolate in the current study was typed in the
respective laboratory of origin by amplification with
consensus primers and hybridization to type-specific probes.
The two laboratories at the Ludwig Institute in Sao Paulo
and at the University of California Irvine, which centrally
evaluated all samples, were able to amplify with separate
type-specific primers almost 100% of the samples. There-
fore, we are confident that no hypothetical highly diverse
variants were lost due to primer design problems.
To date, only four HPV types had given rise to subtypes,
namely HPV-20, 34, 44, and 68 as well as two ape PV (Van
Ranst et al., 1992; de Villiers et al., 2004). We recentlyFig. 1. The intratype diversity of HPV-53. The phylogenetic trees represent the re
control region (LCR). The large tree is based on the UPGMA, the small tree on the
(BR), Hong Kong (HK), Monterrey in Mexico (MX), Edinburgh in Scotland (ED),
(ML). The natural root of this UPGMA tree and those shown in Figs. 2 and 3 are n
the deepest branches.investigated two of these, HPV-44 and 68, and found
distances of up to 10% of the LCR sequences between the
prototypes and the subtypes (Calleja-Macias et al., 2005).
Each of the subtypes has evolved by a dichotomic split,
giving rise to clusters of closely related variants, each cluster
representing one of the two subtypes. All other HPV types
studied, namely HPV-2, 5, 6, 11, 16, 18, 27, and 57 (Deau et
al., 1993; Ho et al., 1993; Ong et al., 1993; Heinzel et al.,
1995; Stewart et al., 1996; Chan et al., 1997; Yamada et al.,
1997), gave rise to multiple short branches, which we refer
to as ‘‘star-phylogenies’’. Interestingly, our study of HPV-53
and 56 showed a dichotomic branching pattern similar to
that observed for subtypes pointing to evolutionary pro-
cesses that may lead to new HPV subtypes and eventually
types.
The process that gives rise to phylogenetic branches, be it
the short branches typical of many HPV variants, or the
dichotomic branches of subtypes, or the branching events that
lead to new HPV types, are not well understood. Processes
such as simple genetic drift and some positive selection
would possibly suffice to explain these patterns since variants
with favorable properties (such as faster replication, more
efficient infection) would over time predominate in a
population, and less fit variants would arithmetically dis-
appear, without hypothetical competition or selection. The
quantitative limitation to diversification of each HPV type
may be best explained by a genetic bottleneck. For example,
the human population at the origin of the human host species
may have been a very small number of individuals, limiting
the number and therefore also diversity of HPV genomes that
entered the subsequently expanding population.
Lastly, we did observe a limited amount of specificity of
variants for geographic and ethnic origin, but not as strictly
correlative as in the case of HPV-16 and HPV-18 (Ho et
al., 1993; Ong et al., 1993, Stewart et al., 1996; Yamada et
al., 1997). It may be noteworthy that this poorer correlation
was observed with HPV types that are rare in comparison
to HPV-16 and HPV-18. It is not understood why different
HPV types have quite divergent prevalence, but intuitively
one may propose that abundant HPV types may multiply
and spread faster than rare types. This could imply that the
diversification of rare HPV types took place on a different
time scale to that of HPV-16 and 18 that is not consistent
with the spread of human ethnic groups around the world.
For instance, the observation that the HPV-66 prototype
was found abundantly in patients from South Africa and
Scotland could be explained if the HPV-66 genome as it
exists today was already extant more than 100,000 years
ago.lationship between HPV-53 variants based on a 501 bp segment of the long
neighbor joining algorithm. Samples were obtained from Sao Paulo in Brazil
Cape Town in South Africa (SA), Oklahoma, United States (OK), and Mali
ot known but generated by the computer program at the mid-point between
Fig. 2. The intratype diversity of HPV-56. The phylogenetic trees represent the relationship between HPV-56 variants based on a 549 bp segment of the long
control region (LCR). The large tree is based on the UPGMA, the small tree on the neighbor joining algorithm. Origin of samples as in Fig. 1, three samples
were from Heidelberg, Germany (HE).
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Fig. 3. The intratype diversity of HPV-66. The phylogenetic trees represent the relationship between HPV-66 variants based on a 621 bp segment of the long
control region (LCR). The large tree is based on the UPGMA, the small tree on the neighbor joining algorithm. Origin of samples as in Fig. 1, and one sample
was from Morocco (MR).
J.C. Prado et al. / Virology 340 (2005) 95–104 101
Fig. 4. Diversity of the E6 genes (three panels on the right side of the figure) and part of the L1 genes (left side of the figure) in distantly related variants of HPV-53, 56, and 66. Within each panel, the first column
lists the variants, whose relative phylogenetic position can be found in Figs. 1, 2, and 3. The central part of the figure identifies nucleotide exchanges (letters) or maintenance of the sequence of the reference
genome (gray squares). The box on the right side of each panel informs whether the amino acid sequence of the reference clone has been maintained (‘‘prototype’’) or whether and what kind of amino acid
exchanges had occurred.
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Sample collection
In order to explore the intratype phylogeny of HPV-53,
56, and 66, we examined the sequence diversity within the
long control region (LCR) of isolates from six geographi-
cally and ethnically remote cohorts from Brazil (BR), Hong
Kong (HK), Mexico (MX), Scotland (ED, Edinburgh),
South Africa (SA), Oklahoma, and United States (OK) with
inclusion of some samples from Germany (HE, Heidelberg),
Mali (ML), and Morocco (MR). All patients from Hong
Kong were ethnic Chinese, all samples from South Africa
were obtained from Cape Town patients with an exclusive
or predominant African genetic background. All samples
had been collected during ongoing diagnostic and epide-
miological research of cervical smears in studies that are
unrelated to the objectives of our project. No patient was
sampled solely for the purpose of our research.
HPV-53
Genomic segments of HPV-53 were amplified by
polymerase chain reaction (PCR) using the primers HPV-
53-F, 5V-TTTGCATGTTGTTAATAAATAT-3V, and HPV-
53-R, 5V-AGTAGGATTGTTACTTTC-3V, which generated
a 602 bp segment, between the genomic positions 7270 and
15. The amplicons were directly sequenced with the primers
HPV-53-Fa, 5V-TGGTGTCCCTAGGCAGTTGG-3V, and
HPV-53-R. The genomic sequence was established for 501
bp of the 602 bp fragment. The sequences of all 44 isolates
are published with the GenBank access codes AY949045–
AY949087. In order to exclude possible PCR artifacts, all
samples were amplified twice, and both strands were
sequenced twice. The same precaution applied to the treat-
ment of the HPV-56 and HPV-66 samples.
HPV-56
Genomic segments of HPV-56 were amplified by PCR
with the primers 56-F (5V-TGTGTCATTATTGTGG-
CTTTTGTTTTGT-3V) and 56-R (5V-AGCTGCCTTTTA-
TATGTACCGTTTTC-3V), which generated a 603 bp
segment between the genomic positions 7323 and 81. The
genomic sequence was established for 549 bp of the 603 bp
fragment. The sequences of all 59 isolates are published
with the GenBank access codes AY949088–AY949146.
HPV-66
Genomic segments of HPV-66 were amplified by PCR
with the 66-F (5V-AACGATAGTTGTGTGTTGTG-3V) and
66-R (5V-ACCTGTTTTAGCACGACC-3V), resulting in a
659 bp fragment between genomic positions 7151 and
7810. The genomic sequence was established for 621 of
the 659 bp fragment. The sequences of all 31 isolates aredeposited in GenBank under the access codes AY949147–
AY949176.
Amplification with E6 and L1 consensus primers
The HPV-53, 56, and 66 E6 genes were amplified with
the consensus primers LCR-S (5V-AAGGGAGTAACC-
GAAAACGGT-3V) and E7-AS (5V-TCATCCTCCTCCTCT-
GAG-3V) (Noda et al., 1998), which generated a 650 bp
segment. The genomic sequence was established for 464 bp
(HPV-53 and 56) and 467 bp (HPV-66), respectively, of
these 650 bp. 450 bp fragments of the L1 genes were
amplified with the consensus primers MY09/MY11 (Bauer
et al., 1991; Bernard et al., 1994), and the genomic sequence
was established for 390 bp of these 450 bp. The sequences
of all isolates are published with the GenBank access codes
DQ007159–DQ007188.
PCR amplification, sequence analysis, and phylogenetic
evaluations
The PCR amplicons were electrophoretically separated on
2% agarose gel, purified with ExoI and alkaline phosphatase
(USB, Cleveland OH), and applied to enzymatic extension
reactions for DNA sequencing using the ABI PRISM
BigDye Cycle Sequencing Kit (AB Applied Biosystems).
Both strands were sequenced with the same forward and
reverse primers as those used for PCR amplification of the
LCR unless stated differently. The sequencing reactions were
purified by ethanol/sodium acetate precipitation and then run
on an ABI Prism 3100 sequencer. The mutations were
analyzed and determined by the ALIGN program at the
GENESTREAM network server (Pearson et al., 1997, http://
www2.igh.curs.fr/bin/align-guess.cgi). The Neighbor-join-
ing and unweighted pair-group method with arithmetic
average (UPGMA) trees were constructed using Mega
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